Christopher R. Curtin

Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses

Shuchean Chien, Mark Rogge, L. G. Gisclon et al. · Antimicrobial Agents and Chemotherapy · 1997 · 217 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12

Pharmacokinetics and Pharmacodynamics of Canagliflozin, a Sodium Glucose Co‐Transporter 2 Inhibitor, in Subjects With Type 2 Diabetes Mellitus

Damayanthi Devineni, Christopher R. Curtin, David Polidori et al. · The Journal of Clinical Pharmacology · 2013 · 216 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Topiramate and Phenytoin Pharmacokinetics During Repetitive Monotherapy and Combination Therapy to Epileptic Patients

Rǎjesh C. Sachdeo, S. K. Sachdeo, René H. Levy et al. · Epilepsia · 2002 · 75 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Single-Dose Pharmacokinetics of Intravenous Itraconazole and Hydroxypropyl-β-Cyclodextrin in Infants, Children, and Adolescents

Susan M. Abdel‐Rahman, Richard F. Jacobs, Joseph Massarella et al. · Antimicrobial Agents and Chemotherapy · 2007 · 53 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +17

Effect of Hepatic or Renal Impairment on the Pharmacokinetics of Canagliflozin, a Sodium Glucose Co-transporter 2 Inhibitor

Damayanthi Devineni, Christopher R. Curtin, Thomas Marbury et al. · Clinical Therapeutics · 2015 · 49 citations

Pharmacy, Pharmacokinetics, Pharmacology +14